All Stories

  1. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy
  2. Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib
  3. Analysis of a nanoparticle‑enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis
  4. Functional Role of microRNA-23b-3p Cancer Biology tumour suppressor miR Exosome miR
  5. Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers
  6. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
  7. miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease
  8. Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes
  9. Environment and bladder cancer: molecular analysis by interaction networks
  10. Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells
  11. Biological Function of MicroRNA193a-3p in Health and Disease
  12. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
  13. Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis
  14. Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells
  15. De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay
  16. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
  17. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
  18. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression
  19. The Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration
  20. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells
  21. Proteomic Identification of LASP-1 Down-regulation After RNAi Urokinase Silencing in Human Hepatocellular Carcinoma Cells
  22. RET/PTC1-Driven Neoplastic Transformation and Proinvasive Phenotype of Human Thyrocytes Involve Met Induction and β-Catenin Nuclear Translocation
  23. RNA Interference against Urokinase in Hepatocellular Carcinoma Xenografts in Nude Mice
  24. Matrix Assembly Induction and Cell Migration and Invasion Inhibition by a 13-Amino Acid Fibronectin Peptide
  25. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells
  26. Induction of Fibronectin mRNA by Urokinase- and Tissue-Type Plasminogen Activator in Human Skin Fibroblasts: Differential Role of u-PA and t-PA at the Fibronectin Protein Level
  27. Gene Response of Human Skin Fibroblasts to Urokinase-and Tissue-Type Plasminogen Activators
  28. Phosphorylation of human plasminogen activators and plasminogen
  29. Urokinase-Type and Tissue-Type Plasminogen Activators as Growth Factors of Human Fibroblasts
  30. RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: Molecular markers for hepatocellular carcinoma
  31. Interaction of tissue-type plasminogen activator with fibronectin and fibronectin fragments
  32. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients
  33. Characterisation of fibronectin fragments and plasminogen activators released by RSV-transformed cells
  34. A rapid and highly sensitive solid-phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody
  35. Tissue type plasminogen activator, but not urokinase, exerts transformation-enhancing activity
  36. Monoclonal antibody against theN-terminal end of human plasma fibronectin
  37. Transformation-enhancing activity in plasma of tumor patients: Relationship with fibronectin fragments
  38. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
  39. Inhibition of rous sarcoma-virus-induced transformation by proteins involved in blood coagulation